Repligen Corporation (RGEN) financial statements (2021 and earlier)

Company profile

Business Address 41 SEYON STREET
WALTHAM, MA 02453
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments528194174142725862
Cash and cash equivalents528194174122543540
Short-term investments   20182322
Receivables443628171285
Inventory, net of allowances, customer advances and progress billings55423925181212
Inventory55423925181212
Prepaid expense3110110
Deferred costs 0000  
Deposits current assets     0 
Other current assets1100000
Other undisclosed current assets11211117
Total current assets:6422762431841038186
Noncurrent Assets
Operating lease, right-of-use asset26
Property, plant and equipment48322215141513
Long-term investments and receivables    2412
Long-term investments    2412
Intangible assets, net (including goodwill)6814624728927297
Goodwill4683273276014141
Intangible assets, net (excluding goodwill)2131351453013156
Restricted cash and investments   0000
Other noncurrent assets006    
Deferred tax assets, net4     
Other undisclosed noncurrent assets3     0
Total noncurrent assets:758499501105434732
TOTAL ASSETS:1,400775744289146128119
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities45262521191517
Accounts payable111075742
Accrued liabilities3316181612710
Employee-related liabilities     43
Taxes payable     12
Debt4103     
Business combination, contingent consideration, liability     1
Deferred revenue and credits   00
Other liabilities      1
Other undisclosed current liabilities     (6)(7)
Total current liabilities:481302521191111
Noncurrent Liabilities
Long-term debt and lease obligation260 9995   
Long-term debt, excluding current maturities233 9995   
Operating lease, liability27
Liabilities, other than long-term debt229284563
Deferred tax liabilities, net2525    
Other liabilities2424563
Other undisclosed noncurrent liabilities30      
Total noncurrent liabilities:2922912799563
Total liabilities:340159152120231715
Stockholders' equity
Stockholders' equity attributable to parent1,060616592169123112104
Common stock1000000
Additional paid in capital1,068643629242203198191
Accumulated other comprehensive income (loss)(15)(12)(6)(14)(9)(6)2
Retained earnings (accumulated deficit)6(16)(32)(60)(72)(81)(89)
Total stockholders' equity:1,060616592169123112104
TOTAL LIABILITIES AND EQUITY:1,400775744289146128119

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues270194141105846468
Revenue, net141105846468
Cost of revenue(119)(87)(67)(50)(39)(28)(25)
Cost of goods and services sold(119)(87)(67)(47)(35)(28)(25)
Gross profit:1511087454443643
Operating expenses(115)(82)(60)(38)(30)(27)(23)
Other undisclosed operating income     23
Operating income:36261416141123
Nonoperating income (expense)(10)(5)(0)(1)(0)00
Investment income, nonoperating5200000
Other nonoperating income (expense)(0)0(1)(1)(0)0(0)
Interest and debt expense(6)(7)(6)(4)(0)(0)(0)
Income from continuing operations before equity method investments, income taxes:2115712131123
Other undisclosed income from continuing operations before income taxes67     
Income from continuing operations before income taxes:2621712131123
Income tax expense (benefit)(5)(5)21(0)(4)(3)(7)
Net income available to common stockholders, diluted:211728129816

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income:211728129816
Other comprehensive loss    (3)  
Comprehensive income:211728127816
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(3)(6)7(5) (8)0
Comprehensive income, net of tax, attributable to parent:18113667016

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: